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Abstract Quantum dots (QDs) are fluorescence
nanoparticles (NPs) with unique optic properties
which allow their use as probes in chemical, biolog-
ical, immunological, and molecular imaging. QDs
linked with target ligands such as peptides or small
molecules can be used as tumor biomarkers. These
particles are a promising tool for selective, fast, and
sensitive tagging and imaging in medicine. In this
study, an attempt was made to use QDs as a marker for
human metallothionein (MT) isoforms 1 and 2. Four
kinds of CdTe QDs of different sizes bioconjugated
with MT were analyzed using the chip-CE technique.
Based on the results, it can be concluded that MT is
willing to interact with QDs, and the chip-CE
technique enables the observation of their complexes.
It was also observed that changes ranging roughly
6–7 kDa, a value corresponding to the MT monomer,
depend on the hydrodynamic diameters of QDs; also,
the MT sample without cadmium interacted stronger
with QDs than MT saturated with cadmium. Results
show that MT is willing to interact with smaller QDs
(blue CdTe) rather than larger ones QDs (red CdTe).
To our knowledge, chip-CE has not previously been
applied in the study of CdTe QDs interaction withMT.
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Metallothionein: structure and properties
MT was first isolated from a horse kidney in 1957 by
Margoshes and Vallee as a cadmium binding protein
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of low molecular weight (about 6 kDa) (Margoshes
and Vallee 1957). Nearly 30 % of the protein consist
of cysteines, each containing one SH group which
gives them the ability to bind metal ions (Bremner and
Beattie 1990; Duncan and Stillman 2006). MT plays
an important role in the homeostasis of heavy metals
(Coyle et al. 2002; Sabolic et al. 2010), protection
against oxidative stress (Bizon et al. 2011; Ruttkay-
Nedecky et al. 2013), and DNA damage (Cai et al.
2000; Chubatsu and Meneghini 1993). MT is involved
in the regulation of gene expression and transcription
(Andrews 2000; Davis and Cousins 2000), enzyme
activation (Krizkova et al. 2009a; Zalewska et al.
2014), and other biological processes.
Four major isoforms have been identified in mam-
mals: MT-1, MT-2, MT-3, and MT-4 (Simpkins
2000). The best known isoforms MT-1 and MT-2 are
expressed in nearly all types of tissues. Thanks to the
presence of sulfur-based metal clusters in the particle,
MT can bind with 7 Zn (II), Cd (II) or 12 Ag (I), Cu
(I) ions per molecule. TheMT binding affinity to metal
ions differs between various metals or is metal
dependent. For rat liver MT, the relative affinities of
MT for Cd (II) were higher than for Zn (II) (Waalkes
et al. 1984), while higher affinities of MT than for Cd
(II) were found for Cu (I), Hg(II) and Ag (I) (Nielson
et al. 1985; Hamer 1986). This indicates that Cd (II)
ions can displace Zn (II) from MT structure. The main
roles of MT-1 and MT-2 are detoxification of heavy
metals from the body and protection against oxidative
compounds (Bizon et al. 2011; Kagi and Schaffer
1988; Krizkova et al. 2010a; Moffatt and Denizeau
1997). MT-3 has been found mainly in the central
nervous system (brain tissue), but also in kidneys, the
heart, and reproductive organs, whereas MT-4 occurs
in epithelial cells (Ruttkay-Nedecky et al. 2013; Vasak
and Meloni 2011; Wang et al. 2006). MT-3 was first
identified by Uchida et al. and originally termed a
growth inhibitory factor (Uchida et al. 1991). MT-3
plays an important role not only in brain diseases,
particularly in Alzheimer’s disease, but also in
Parkinson’s disease and cognitive disorders (Carpene
et al. 2007; Craig-Schapiro et al. 2009; Manso et al.
2012; Vasak and Meloni 2011).
Changes in the expression of MT could be a
prognostic marker in the development of tumor
malignancies, such as breast, prostate, ovary, head,
and neck, or small-cell lung cancer, melanoma, and
soft tissue sarcomas (Cherian et al. 2003; Krizkova
et al. 2009b; Krizkova et al. 2010b; Krizkova et al.
2011; Namdarghanbari et al. 2011). However, the
expression level of this protein is not universal for all
human tumors and may depend on the state of tumor
proliferation. Over the last decade, some data have
appeared illustrating that induction of MT can be used
as an adjunct in cancer chemotherapy, to prevent the
toxicity caused by gamma radiation or the action of
cisplatin, as well as by other chemotherapeutic agents
(Doz et al. 1993; Karotki and Vasak 2009; Koberle
et al. 2010; Sogawa et al. 2013). Previously published
papers show that there are significant problems with
the identification and monitoring of MT expression
and its concentration. The challenge is to develop
techniques for a selective, sensitive, and rapid labeling
of this protein.
Preparation of QDs and their application
Because of the changes in structural and functional
properties, resulting from reductions in their size,
nanomaterials have become very popular. An addi-
tional advantage of NPs is the ability to obtain
biocompatible molecules in nanoscale which allows
for quick and easy use of NPs in the field of science
and industry (Niemeyer 2001; Rana et al. 2010; Roco
2003; Salata 2004; Sanvicens and Marco 2008). Of
equally large significance is the development of
fluorescent labeling techniques, due to the possibility
for their use in treatment of individual marking
(targeted therapy) (Brannon-Peppas and Blanchette
2012; Liu et al. 2007), molecular imaging, and also in
chemical and biochemical assays (Drbohlavova et al.
2009; Rao et al. 2007; Terai and Nagano 2013). With
the evolution of nanotechnology, the search for new
biocompatible markers has led to the emergence of
luminescent materials with properties known as
semiconductor quantum dots (QDs) and lanthanide-
doped nanocrystal (Drbohlavova et al. 2009; Gao et al.
2005; Smith et al. 2004; Wang and Li 2007).
QDs are nanocrystals with structures containing
metal atoms of groups II-VI (e.g., CdS, CdTe, ZnSe)
or III-V (e.g., InP, InAs) of the periodic table (Chan
et al. 2002). Luminescence of the particles is due to
quantum effects associated with changes permitted in
electron states. QDs are characterized by the emission
of visible light (depending on the size of the NPs) after
ultraviolet irradiation (UV) (Drbohlavova et al. 2009;
Michalet et al. 2005; Smith et al. 2004).
423 Page 2 of 12 J Nanopart Res (2015) 17:423
123
During the process of QDs preparation, it is
possible to control such conditions as time, tempera-
ture, and type of ligand, thus obtaining the desired
crystallite size and shape. The spectroscopic proper-
ties of QDs strongly depend on the size and shape of
the crystallites (Alivisatos 1996; Drbohlavova et al.
2009; Gao et al. 2005). Moreover, the choice of ligand
to the bioconjugation, such as an antibody or protein
with a good affinity, allows the use of specific QDs for
labeling DNA, proteins, or even cells (Chan and Nie
1998; Frasco and Chaniotakis 2010).
The majority of QDs that have been studied and
used are those which in the core have selenium or
tellurium atoms, because of thewide range of spectrum
emitted by the region containing the atoms of these
elements (Drbohlavova et al. 2009; Frasco and Chan-
iotakis 2010;Michalet et al. 2005; Smith et al. 2004). In
order to reduce the cytotoxicity of QDs and improve
their spectroscopic properties (e.g., elimination of
photobleaching), different synthesis methods have
been developed (Chan et al. 2002; Grieve et al. 2000;
Michalet et al. 2005;Wang and Li 2007). Another way
to reduce QDs cytotoxicity to an acceptable level is by
coating their surface. The surface coating of QDs is
mainly due to their stability, as without it they tend to
aggregate and lose fluorescence. Additionally, it
protects the nanocrystallites from chemical degrada-
tion. QDs may be safely used as fluorescent probes in
biological labeling, markers for monitoring drug
release, and for controlled modification of structural
and functional properties of intracellular components
(Alivisatos 1996; Chan et al. 2002; Chan andNie 1998;
Derfus et al. 2004; Dubois et al. 2007; Frasco and
Chaniotakis 2010; Grieve et al. 2000; Hoshino et al.
2004; Michalet et al. 2005; Wang and Li 2007).
Chip-CE technique
Capillary electrophoresis (CE) is often used to detect
MT and to separate isoforms of MT (Minami et al.
2002; Richards and Beattie 1995; Ryvolova et al.
2012; Zalewska et al. 2011). CE techniques constitute
a family of electrokinetic methods. During CE anal-
ysis through capillaries or micro and nanochannels,
analytes migrate under the influence of the applied
voltage. Separation in these methods is based on ionic
mobility (Righetti et al. 2013; Sieradzka et al. 2014;
Zhu et al. 2012). In addition, CE can also be used for
monitoringMT concentration during illness, as well as
analyzing stability and affinity in the conditions of an
experimental environment (Petersen et al. 2003;
Ryvolova et al. 2012; Swinney and Bornhop 2000).
It is also proposed to apply this technique in exper-
iments involving modification of MT and its ability to
form aggregates and polymers (Krizkova et al. 2009a).
Due to the presence of two domains in the MT
structure: b-domain (N-terminus, Me(II)3Cys9) and a-
domain (C-terminus, Me(II)4Cys11) and the high
affinity to bind Cd because of Cd-S bond formation,
it is possible to observe the interaction of CdTe with
MT (Skalickova et al. 2013; Thormann et al. 2001).
For the determination of bioconjugates of QDs with
MT, a technique is needed that allows for the
simultaneous analysis of several samples with high
efficiency in a relatively short time. Chip-CE can be
used as a tool to effectively and efficiently analyze the
marking of MT with QDs. To our knowledge, chip-CE
has not been applied in the study of CdTe nanopar-
ticles interaction with MT to date.
In this study, we have attempted to show the
differences in the interaction of QDs with human MT,
which depend on different sizes of QDs. The obtained




Chemicals such as mercaptosuccinic acid (MSA),
cadmium acetate, cadmium chloride (99.999 %), and
sodium tellurite were purchased from Sigma Aldrich
(St. Louis,MO, USA). Two stock solutions (50 lg/mL
of Cd(II) and 500 lg/mL ofMSA)were prepared daily
and subsequently diluted to the appropriate concentra-
tion just prior to use. As a supporting electrolyte, 0.2 M
acetate buffer of pH 5was used. High-purity deionized
water was used throughout the study (Milli-Q Milli-
pore 18.2 MX/cm, Bedford, MA, USA).
Sample preparation
Human liver metallothionein was obtained according
to procedure described previously (Milnerowicz and
Bizon 2010). Briefly, pieces of human liver were
washed several times with PBS (the study protocol was
approved by the Local Bioethics Committee (KB No
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165/1999)). The tissue was homogenized in a buffer
(10 mM Tris/HCl, pH 8.6, 10 mM b-mercaptoethanol
and 25 mM sucrose) with a ratio of 1:4 (v/v). The
resulting homogenate was centrifuged each time at
4 C in three stages under the following conditions: 1—
50009g speed for 25 min, 2—speed of 10,0009g for
1 h, 3—speed 105,0009g for 2 h. The obtained
supernatant was separated into two samples wherein
one of them (Cd-MT) was saturated with CdCl2 and
incubated in a water bath at 80 C for 10 min and
stirred. Both cytosol fractions (nonCd-MT and Cd-MT)
were precipitated with acetone in scope from 60 % to
80 % (left overnight). After centrifugation, the resulting
precipitates were dissolved in Tris-HCl pH 8.6 and
centrifuged again. The samples were applied to a
Sephadex G-75 column. Fractions containing MT were
verified by SDS/PAGE, Western Blot, and ELISA
(Milnerowicz and Bizon 2010). The samples containing
human MT (both isoforms MT-1 and MT-2) were
concentrated by Cut-off filter 3 K (Amicon Ultra-0.5
Centrifugal Filter Devices) prior to analysis on
MALDI-TOF/TOF (supplementary material 2).
CdTe QDs synthesis
The method of CdTe QDs preparation was previously
published by Duan et al. (2009). A spare solution of
CdTeQDswas prepared by dissolving cadmium acetate
dihydrate (0.044 g) in 76 mL of MiliQ water in a
200 mL beaker on a magnetic stirrer. Then, mercapto-
succinic acid (MSA) (60 mg) in water (1 mL) was
added followed by 1.8 mL of 1 M NH3. Finally, a
solution of Na2TeO3 (0.0055 g) in water was added and
after a fewminutes 40 mgofNaBH4waspoured into the
stirred solution. The solution was stirred for 1 h, its
volume was adjusted to 100 mL with the addition of
water, after which it was heated in vials filledwith 2 mL
of the solution in a Multiwave 300 microwave oven
(Anton Paar GmbH, Graz, Austria) (300 W, 10 min).
CdTe QDs were prepared at various temperatures
according to emission color (50 C—blue, 70 C—
green; 90 C—yellow; 130 C—red, Fig. 1).
Dynamic light scattering
The average particle hydrodynamic parameter and
diameters distribution of the nanoparticles were
determined by a Zetasizer (Malvern-zetasizer Nano
ZS, Malvern, UK) at 25 C. The measurement was
performed after diluting the solution with deionized
water. Size as hydrodynamic diameter is modeled by
Stokes–Einstein equation (Murdock et al. 2008). The
hydrodynamic parameter of quantum dots increased
with the increasing temperature of the preparation
process. The sizes (hydrodynamic diameters) of the
nanoparticles were as follows: 3.4 nm (blue QDs),
3.8 nm (green QDs), 4.5 nm (yellow QDs), and
5.2 nm (red QDs).
Conjugation of QDs with MT
4 lL of each sample of Cd-MT and nonCd-MT
consisting of both isoforms (MT-1 and MT-2) at a
concentration 0.1 mg/mL was mixed with 4 lL of
each QDs. The mixture was incubated for 2 h at 20 C
in a thermoblock (Eppendorf thermomixer, Germany).
Chip-CE
Analyses using an automated microfluidic Experion
electrophoresis system (Bio-Rad, USA) were carried
out according to the manufacturer’s instructions with
supplied chemicals (Experion Pro260 analysis kit,
Bio-Rad). The kit allows for fast and reproducible
protein analysis with a separation range of 10–260 kD
with 2.5 ng/lL sensitivity; detection was performed
using colloidal Coomassie Blue gel staining. The
presence of the ladder (as a standard) allowed
correlation of migration time with molecular weight.
A sample analysis was carried out according to the
following steps:
1. Priming the chip—microchannels were filled in
with the microfluidic gel-stain solution (with
Fig. 1 Picture shows synthetic blue, green, yellow and redQDs
respectively after ilumination using UV transiluminator (254
nm). (Color figure online)
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fluorescent dye). 0.2 lg of both MT samples
(nonCd-MT and Cd-MT) was used per one chip-
CE sample. A 4 lL of each sample was mixed
with 2 lL of non-reducing sample buffer without
heating (30 lL of the sample buffer with 1 lL of
water), and 84 lL of water was added. The ladder
was prepared in reducing conditions (30 lL of the
sample buffer with 1 lL of b-mercaptoethanol
(total concentration of b-mercaptoethanol is
3.3 % (v/v), 95 C, 5 min). After priming the
chip with the gel and gel-staining solution, the
sample (6 lL) was loaded into the sample well.
The Pro260 Ladder included in the kit was used as
a standard.
2. The prepared chip was inserted into the elec-
trophoresis station. During separation performed
at 21 C (voltage: 100–240 V), the fluorescent
dye associated with the lithium dodecyl sulfate
(LDS) coating the proteins.
3. As the molecules migrated towards the end of the
separation channel, a laser excited the dye,
causing it to fluorescence (Bousse et al. 2001).
Fluorimetric measurement
Fluorescence and absorbance spectra were acquired
with a multifunctional microplate reader EnSpire
Multimode Reader (PerkinElmer, USA). The absor-
bance scan was measured within a range of
350–750 nm (Fig. 2a). Based on the results obtained,
400 nm was used as an excitation wavelength and the
fluorescence scans were measured within the range
from 440–840 nm per 5 nm steps (Fig. 2b). Each
intensity value is an average of 5 measurements.
15 lL of each QDs were mixed with 15 lL of each
sample of nonCd-MT and Cd-MT (consisting of two
isoforms (MT-1 and MT-2) with the concentration of
0.1 lg). After 2 h of incubation, the mixed samples
were placed in a transparent 96-well microplate with a
flat bottom by Nunc (Thermo Scientific, USA).
Results
The synthesized QDs exhibited various colors after
excitation with UV light (254 nm) (Fig. 1). The
resulting products were characterized with the use of
fluorescence spectroscopy (Fig. 2b). After interaction
of QDs with Cd-MT and nonCd-MT (2 h incubation of
each QD with each MT sample, for details see
Material and Methods section), different fluorescent
behaviors of Cd-MT and nonCd-MT was observed
(Fig. 3). On the fluorescence intensity spectra, higher
peaks were present for nonCd-MT with blue QDs (675
AU) and with red QDs (1440 AU) than for lone blue
QDs (221 AU) and red QDs (1136 AU), respectively
(Figs. 2b, 3a). The fluorescence intensity was the same
for yellow QDs with nonCd-MT (1409 AU) and
yellow QDs (1409 AU, Fig. 2b), whereas the peak
obtained for green QDs with nonCd-MT (1590 AU)
was lower than the peak for green QDs alone (2098
AU) (Fig. 3a).
The fluorescence intensity spectrum for Cd-MT
shows higher peaks for Cd-MT with blue QDs and red






















































Fig. 2 Absorbance (a) and
fluorescence spectra (b) of
blue, green, yellow and red
QDs. (Color figure online)
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compared to the peaks obtained for blue and red QDs
alone (Fig. 2b). The peaks obtained for Cd-MT with
green QDs (1204 AU) and yellow QDs (1230 AU)
(Fig. 3b) were lower than the peaks obtained for green
and yellow QDs alone (Fig. 2b).
On the fluorescence spectra, it was observed that
the peak obtained for Cd-MT ? red QDs (1820 AU)
was higher than the peak obtained for nonCd-MT
(1440 AU) (Fig. 3a, b). However, the peaks obtained
for nonCd-MT with blue (675 AU), green (1590 AU),
and yellow QDs (1409 AU) (Fig. 3a) were higher than
the peaks obtained for Cd-MT with blue (415 AU),
green (1204 AU), and yellow QDs (1230 AU),
respectively (Fig. 2b).
Interaction of Cd-MT and nonCd-MT with QDs
was studied also using chip capillary electrophoresis.
The chip-CE electropherogram for nonCd-MT shows
three main peaks sized 3.2 kDa, 7.0 kDa, and
15.4 kDa corresponding to migration times at: 24.0,
28.2, and 34.0 s, respectively (Fig. 4a, b). The signal
of the system peak for nonCd-MT characterized by a
time shift in the migration time range of 23.7–30.0 s
(1.9–7.0 kDa) could be compared to the ladder system
peak, which was detected at 28 s (6.8 kDa) (supple-
mentary material 2).
On the electropherograms with Cd-MT, three main
peaks were observed with the sizes of 6.0, 9.2, and
40 kDa corresponding tomigration times at 27.2, 30.7,
and 41.5 s, respectively (Fig. 4c, d). Signal of the
system peak for Cd-MT characterized by the time shift
in migration time range 23.6–30.4 s (2.9–8.9 kDa)
could be compared to the ladder system peak, which

















































































































+ water + Cd-MT
Fig. 3 Fluorescence intensity of bioconjugated QDs with (a) nonCd-MT and (b) Cd-MT. In insets are shown the differences obtained
in emission maxima. (Color figure online)
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The obtained peaks for both samples (nonCd-MT
and Cd-MT) withMr of roughly 6–7 kDa indicated the
presence of MT monomers; however, the monomers
co-migrated with a system peak, and thus, their correct
sizing is not possible. For nonCd-MT, an additional
peak with 15.4 kDa was noted, which may indicate the
presence of dimers MT (Fig. 4a, b). For Cd-MT, an
additional peak was noted at about 37–40 kDa which
may indicate the presence of oligomers. The graphs
show shifted peaks and differences in Mr for nonCd-
MT monomers (Mr = 7.0 kDa, t = 30.0 s) and Cd-
MT monomers (Mr = 6.0 kDa, t = 27.2 s). Further-
more, differences in the migration time (and Mr) for
the second main peak were observed at 36.3 s
(15.4 kDa) for nonCd-MT and at 30.7 s (9.2 kDa)
for Cd-MT.
To prove that the signals observed for samples of
MT bioconjugated with QDs were not derived from
QDs, an electropherogram was performed for four
different QDs (Fig. 4e, f). The peaks for blue,
green, yellow, and red QDs alone corresponded to
6.6 kDa (t = 27.6 s), 6.4 kDa (t = 27.4 s), 6.8 kDa
(t = 28.0 s), and 6.7 kDa (t = 27.6 s) Mr, respec-
tively (Fig. 4e, f). The range migration times for
systems peaks were observed at 24.5 s (2.5 kDa)–
29.5 s (6.6 kDa) for blue QDs, 24.3 s (2.3 kDa)–
29.7 s (6.7 kDa) for green QDs, 24.9 s (2.8 kDa)–
29.8 s (6.9 kDa) for yellow QDs, and 24.8 s
(2.7 kDa)–29.6 s (6.7 kDa) for red QDs (Fig. 4e). It
was observed that the system peak obtained for
nonCd-MT was shifted in time when compared to
the system peaks obtained for each QDs (Fig. 4a, e).
The graphs in Fig. 4a show that the addition of
CdTe QDs to nonCd-MT led to the intensities of the
peaks at 28 s increasing, which may be explained by
















































































































































































































































Fig. 4 Electrophoreograms of: (a) bioconjugated nonCd-MT with QDs, (c) bioconjugated Cd-MT with QDs and (e) QDs. (b), (d) and
(f) are a gel of nonCd-MT with QDs, Cd-MT with QDs and four QDs respectively. (Color figure online)
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observed fluorescence intensity for peaks at the
positions of roughly 28, 34, and 41 s for blue and
red QDs-nonCd-MT complexes was higher than the
fluorescence intensity obtained for others
QDs?nonCd-MT complexes (Fig. 4a). It shows that
nonCd-MT prefers to interact with blue and red QDs
rather than with others QDs.
The peak at about 34 s (Mr = 15 kDa) may
indicate the presence of MT dimers (Fig. 4a, b). The
graphs show that MT dimers are likely to combine
with green QDs rather than with blue ones (Fig. 4a),
which corresponds to the larger increase in the peak
obtained for green QDs-(nonCd-MT) complexes
rather than blue QDs-(nonCd-MT) when compared
to nonCd-MT.
In the case of Cd-MT, the addition of QDs (Fig. 4c,
d) shows that peaks observed for Cd-MT complexes
with QDs at 27 s decreased and shifted towards higher
Mr in comparison with Cd-MT. It was observed that
the largest number of Cd-MT particles bound to the
smallest sized QDs (blue QDs) (Fig. 4c). Intensities of
the peaks for complexes of Cd-MT with green and
yellow QDs observed at 31 s were slightly increased,
while intensities for the complexes of Cd-MT with
blue and red QDs were comparable to Cd-MT alone,
but with time shifted towards higher Mr depending on
their size (Fig. 4c). For green QDs, the obtained peak
occurred later in time, which means that larger
aggregates of cadmium MT are more likely to
combine with them than with the smaller ones (blue
CdTe) or the largest ones (red CdTe, Fig. 4c, d).
At the position of roughly 41 s (Mr 37.2 kDa for
Cd-MT) (Fig. 4c), new peaks occurred for all com-
plexes of QDs with Cd-MT (Fig. 3c, d). Increased
intensities at 41–43 s were observed for complexes of
Cd-MT with yellow (the highest) and green and red
(similar intensities) QDs compared with Cd-MT alone
(t = 41.5 s, 37.2 kDa). At 42–43 s, a time shift
towards higher Mr for all QDs was also observed
(e.g., 39.1 kDa for Cd-MT?green QDs, 40.0 kDa for
Cd-MT?yellow QDs) (Fig. 4c).
Discussion
A large number of publications have been reported on
the validity of the determination of MT as a tumor
marker (Cherian et al. 2003; Krizkova et al. 2010b;
Krizkova et al. 2011). An important factor would be
the selection of such a method that would allow for
both sensitive and selective analysis ofMT presence in
body fluids.
The application of QDs as a marker for peptides
(Rosenthal et al. 2011), proteins (Miyawaki et al.
2003) or DNA (Mitchell et al. 1999) is well known.
Using luminescence QDs as a tumor biomarker seems
to be an effective method of tagging at the molecular
level (Chan et al. 2002; Gao et al. 2005; Mitchell et al.
1999). The mechanisms by which QDs bind to
biomolecules are still being explored (Gao et al.
2005; Mitchell et al. 1999; Miyawaki et al. 2003; Pons
et al. 2006). It is worth mentioning the fact that the
type of interaction depends on the geometric orienta-
tion of biomolecules and hydrodynamic sizes of QDs
(Michalet et al. 2005; Pons et al. 2006). Researchers
point out that QDs can interact with proteins through
the presence of cysteine residues (Miyawaki et al.
2003; Rosenthal et al. 2011). The use of QDs in
medicine and biochemistry appears to be a promising
technique that allows for quick labeling and analysis
of proteins. The advantage of this technique seems to
be the ability to control and influence the properties of
QDs through manipulation in the selection of ligand or
a change of reaction (Chan et al. 2002; Michalet et al.
2005). In addition, QDs can provide usable imagery
due to their fluorescent properties. It is important to
ensure the safety and reduce the cytotoxicity of these
probes, for example, by decreasing the surface defect
density (Silva et al. 2014). In the cited article, the
authors showed that increasing concentrations of Se
reduced the toxic effects of CdSe QDs. It was noted
that due to the affinity of cadmium to MT, the
interaction of this protein with CdTe QDs is possible,
and that reduced presence of Cd2? diminished the
expression of MT mRNA (Silva et al. 2014).
The interaction of MT with QDs is known, and it
has been described using spectrophotometry, fluo-
rimetry and voltammetry (Skalickova et al. 2013).
Through spectral and electrochemical techniques, it
was possible to locate signals of MT after interaction
with QDs in Mr corresponding to MT dimers or
trimers (Tmejova et al. 2014). Oligomerization of MT
after interaction with metals or after oxidation was
previously studied with CE, MS (Hong et al. 2000;
Shen et al. 2006), spectrophotometry (Palumaa and
Vasak 1992), and chip-CE (Krizkova et al. 2010a).
The interaction of MT with QDs can occur not only
under in vitro conditions but also in living organisms,
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as a part of heavy metals detoxification resulting in
biosynthesis of MT-stabilized QDs (Skalickova et al.
2013; Sturzenbaum et al. 2013; Trabelsi et al. 2013).
The chip-CE technique was proposed for the first
time for analysis of MT by Krizkova et al. (Krizkova
et al. 2009a). The authors showed that this technique
can be used to analyzeMT, including to investigate the
effects of oxidation on the structure of MT. Many
commercial platforms for chip electrophoresis allow-
ing routine analysis of nucleic acids or proteins are
available, and their use for NPs analysis has been
tested (Smejkal and Foret 2012). One such example is
the use of this technique for the detection of AgNPs in
common water (Chua and Pumera 2013).
The interactions of MT with QDs described above
were analyzed using various techniques, and the chip-
CE technique was used to analyze MT as well as QDs,
but to our knowledge, chip-CE has not previously been
used for studying interactions of MT with CdTe QDs.
Our results indicate that this technique is suitable for
monitoring proteins interacting with NPs. The
observed increased intensity of peaks for MT-QDs
complexes allows for the use of chip-CE to detect QDs
binding to MT. Unfortunately, due to the presence of
system peaks, an accurate analysis of the MT
monomer is not possible, and it is suspected that a
peak derived from the MT monomer is blocked by the
system peaks (Krizkova et al. 2009a). Nevertheless,
the signal corresponding to the amount of the protein
bound or unbound with QDs allows determination of
binding of MT-QDs depending on the size of CdTe.
The chip-CE technique successfully enabled the
imaging bioconjugation of these QDs with MT, which
can be used in monitoring and identification of this
protein. In this study, we used chip-CE to verify
complexes generated in the process of bioconjugation
of different sizes of CdTe with MT. The interaction
between MT and QDs was also verified using fluores-
cence intensity.
As shown in this report, MT readily combines with
the proposed CdTe due to its affinity for Cd. While in
nonCd-MT complexes with QDs, only slight changes
in peaks’ intensities were observed, in Cd-MT, it was
observed that additional changes in peaks’ time
migration appeared, resulting in a shift to higher Mr
for Cd-MT complexes with QDs (depending on the
hydrodynamic diameter of the QDs) compared to MT
alone. The changes in migration time were most
distinctive for green and yellow QDs. Moreover, for
Cd-MT, we observed new peaks in positions of
37 kDa, which were shifted depending on the size of
QDs. The choice of the size of CdTe QDs allowed us
to analyze not only the MTmonomers but also the MT
oligomers in the sample.
The increase of 31 s peak at Cd-MT-QDs indicated
that MT dimers (10 and 15 kDa) exhibit a higher
affinity with QDs in a Cd-saturated state and form
oligomers (40 kDa) depending on QDs size (for Cd-
MT?red QDs complexes, the intensity decreased at 27
and 31 s but at 41 s increased compared to Cd-MT
alone). Also, on the fluorescence intensity spectra, it
can be noticed that the peak obtained for Cd-MT?red
QDs was higher than the peak obtained for nonCd-
MT?red QDs. This may be connected with Cd-MT
saturation with heavy metals, and thus structure
stabilization of MT and a preferable formation of
aggregates (observed on chip-CE electropherogram at
41–43 s). The peaks of fluorescence intensity obtained
for blue, green, and yellow QDs conjugated with
nonCd-MTwere higher than the peaks obtained for the
same QDs with Cd-MT. This can be explained by
greater affinity for nonCd-MT to bind Cd from QDs
than Cd-MT (due to the saturated binding sites of this
metal) (Carpene et al. 2007; Krizkova et al. 2010a).
Based on these results and taking into account the
role of MT as a prognostic marker in cancerogenesis,
chip-CE can be used as a technique to verify
interaction between protein and NPs.
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